Proceedings of the National Academy of Sciences · 1997 · 87 citations · 47 references
Life SciencesDevelopmental BiologyOncologyDevelopmental Cell BiologyEmbryogenesisEmbryologyAngiogenesisAngiogenesis In CancerDevelopmental PathologyEarly Embryonic DevelopmentMammalian DevelopmentMammalian EmbryologyAngiogenesis In NeoplasmsEmbryonic Development GeneticsEmbryonic TeratologyGestation PeriodMicroscopic CharacterizationMicroscopic InspectionTissue Factor ActivationTumor Growth Dynamics
Previous reports suggest that tissue factor (TF) may play an essential role in embryonic vascular development and tumor angiogenesis. To further examine this relationship, the morphology of fully developed TF-deficient embryos and the growth of TF-deficient teratomas and teratocarcinomas were analyzed. In a 129/Sv genetic background, TF null embryos do not survive beyond mid-gestation. In contrast, 14% of 129/Sv x C57BL/6 TF-deficient embryos escape this early mortality and survive to birth. On gross and microscopic inspection, these late gestation, TF-deficient embryos appear normal. The growth and vascularity of TF(+/+), TF(+/-), and TF(-/-) teratomas and teratocarcinomas are indistinguishable. Thus, tumor-derived TF is not required for tumor growth and angiogenesis and the combined data do not support an essential role for TF in embryonic vascular development.
47
Antibodies, a laboratory manual
Biomedicine & Pharmacotherapy · 1989 · 12.5K citations
Antibodies: A laboratory manual
J.L. · Trends in Biochemical Sciences · 1989 · 5.2K citations
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Peter Carmeliet, Valérie Ferreira, Georg Breier et al. · Nature · 1996 · 4.1K citations
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Napoleone Ferrara, Karen Carver-Moore, Helen Chen et al. · Nature · 1996 · 3.7K citations · Full text